The Boston-based Choate, Hall & Stewart is experienced in managing complex global patent portfolios, with expertise in areas such as cell and gene therapy, antibody development, mRNA, siRNA, and small molecules. The wider IP team is led by Kristen Buteau, who advises pharmaceutical and biotech companies on patent portfolio strategy and product lifecycle management; Brenda Herschbach Jarrell, who guides life sciences companies and investors on IP strategy, transactions, and solutions; and Charles Lyon, who advises on IP due diligence and freedom-to-operate matters. Also key is Brian Reese, skilled in managing complex patent portfolios; Rolando Medina, experienced in preparation, prosecution, and portfolio counseling; and Stephanie Schonewald, specializing in post-grant patent challenges.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Sector knowledge
Testimonials
Collated independently by Legal 500 research team.
‘Really collaborative and smart on the science. They get what we are doing and so can guide us on the best possible approach.'
‘The team is very accessible and pleasant to work with.'
‘Rolando Medina has been a great partner to work with. He is very knowledgeable and strategic in his thinking. He understands the science well and listens to my business needs.'
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
Kristen Buteau; Brenda Herschbach Jarrell; Charles Lyon
Other key lawyers
Brian Reese; Rolando Medina; Stephanie Schonewald